Nurix Therapeutics Announces Presentations at the American
Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948...
Globe Newswire15-03-2023, 03:58
General Fusion and Kyoto Fusioneering Sign MOU to Accelerate Commercialization of Magnetized Target Fusion 11-10-2023, 20:00